Genomma Sets New Pricing Sights

Jul 1, 2013

Genomma Lab is targeting mid-week to retry a sale of up to MXP2bn ($154m) in what would be the Mexican pharmaceutical...

To continue reading please take a free trial, subscribe or login below.

Already have an account?


Subscribe now for unlimited access to all current and archive news, data and market analysis. 


Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial

Upcoming Events


Where will capital markets be busiest in 2017?